Princeton University (Princeton) and New Jersey Health Foundation (NJHF), a not-for-profit organization that supports health-related research and education, have entered into an agreement that potentially provides $10 million over the next five years to support healthcare and drug discovery-related technology projects. Through this new collaborative framework, NJHF may contribute $2 million a year to support Princeton’s groundbreaking translational research and the start-up companies that hope to build upon that research for public use and benefit.

Present at the signing at Princeton University were: (Standing, L-R): Michael  Wiley, NJHF VP; James  Golubieski, NJHF President; Tony Williams, Princeton University New Venture Associate; Dean R. Edelman, from the Princeton University Office of Corporate Engagement; (Seated, L-R) George F. Heinrich, M.D., NJHF Vice Chair and CEO; and John Ritter, Director, Princeton University Office of Technology Licensing.